Name: rac Etodolac-[d3]
Brand: BOC Sciences
Rating: 5 (1 reviews)

General Information

Catalog: BLP-012868

CAS: 1276197-46-6

Molecular Formula: C17H18D3NO3

Molecular Weight: 290.38

Chemical Structure

Description	rac Etodolac-[d3] is the labelled analogue of rac Etodolac, which can be used as an analgesic and anti-inflammatory drug.
Synonyms	rac Etodolac D3; 1,8-(Diethyl-d3)-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic Acid; (RS)-Etodolic Acid-d3; (+/-)-Etodolac-d3; Eccoxolac-d3; Edolan-d3; Etodine-d3; Etogesic-d3; Lodin XL-d3; Lodine-d3; NSC 282126-d3; Napilac-d3; Ramodar-d3; Tedolan-d3; Ultradol-d3; Zedolac-d3
IUPAC Name	2-[8-ethyl-1-(2,2,2-trideuterioethyl)-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid
Related CAS	41340-25-4 (unlabelled)
Canonical SMILES	CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
InChI	InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/i2D3
InChI Key	NNYBQONXHNTVIJ-BMSJAHLVSA-N
Melting Point	>144°C (dec.)
Purity	95% by HPLC; 98% atom D
Solubility	Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
Appearance	Pale Yellow to Light Yellow Solid
Storage	Store at -20°C

rac Etodolac-[d3] is a deuterium-labeled analog of etodolac, a non-steroidal anti-inflammatory drug (NSAID) utilized in research and pharmaceutical development. Here are the key applications of rac Etodolac-[d3]:

Pharmacokinetic Studies: Delving into the intricate realm of pharmacokinetics, rac Etodolac-[d3] emerges as a pivotal tool for unraveling the metabolic pathways and elimination kinetics of etodolac. The deuterium labeling facilitates precise tracking within biological systems, leveraging mass spectrometry for comprehensive insights. This approach aids in deciphering the absorption, distribution, metabolism, and excretion (ADME) profiles of the drug, shedding light on its journey through the body.

Drug Metabolism Research: In the realm of drug metabolism, rac Etodolac-[d3] serves as a beacon for exploring the metabolic stability and biotransformation processes of etodolac. By scrutinizing the interactions with metabolic enzymes, researchers glean valuable insights into potential drug-drug interactions and metabolic pathways. This knowledge is instrumental in optimizing dosing strategies and minimizing adverse effects in clinical scenarios, shaping the landscape of pharmaceutical research.

Biological Marker in Clinical Trials: Within the realm of clinical trials, rac Etodolac-[d3] assumes a critical role as a biological marker, discerning between endogenous and exogenous sources of etodolac. This differentiation proves indispensable in evaluating the efficacy and safety of the drug across diverse patient cohorts. Leveraging the deuterated form enhances the accuracy and reliability of data collection, paving the way for more robust and insightful clinical trial outcomes.

Analytical Method Development: Serving as an anchor in analytical method development, rac Etodolac-[d3] emerges as an internal standard in assays such as liquid chromatography-mass spectrometry (LC-MS). The stability and distinguishability offered by the deuterium label elevate the precision and sensitivity of these analytical methods. This precision is paramount for upholding the quality and consistency of pharmacological investigations, ensuring adherence to regulatory standards, and advancing the field of analytical chemistry.